10
total announcements
BIOFILCHEM.NS · 15 min delayed
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about a copy of a newspaper publication regarding the notice of the 41st Annual General Meeting and the 15th Annual General Meeting of Veer Global Infraconstruction Limited.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about intimation of e-voting for 41st Annual General Meeting.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not registered with the company/ depository participants, providing the web-link of the website including the exact path where complete details pertaining to the Annual Report is hosted.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026. The meeting will consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2026. Additionally, the meeting will consider the re-appointment of Mr. Smitesh Shah as a Non-Executive Director and the continuation of directorship of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about the publication of a notice of its 41st Annual General Meeting (AGM) through video conferencing or other audio-visual means.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has published unaudited consolidated financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 29.79 lakhs and a total income from operations of Rs. 1,178.50 lakhs.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about the continuation of directorship of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director of the Company, despite him attaining the age of 75 years.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report. The company's board of directors has also approved various businesses, including the continuation of a director's appointment and the convening of the annual general meeting.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June, 2026.
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.